PDS Biotechnology
PDSB
PDSB
65 hedge funds and large institutions have $47.9M invested in PDS Biotechnology in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.96% less ownership
Funds ownership: 23.76% → 20.8% (-3%)
52% less capital invested
Capital invested by funds: $101M → $47.9M (-$52.7M)
Holders
65
Holding in Top 10
1
Calls
$1.53M
Puts
$1.01M
Top Buyers
| 1 | +$822K | |
| 2 | +$743K | |
| 3 | +$639K | |
| 4 |
First Manhattan
New York
|
+$613K |
| 5 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
+$609K |
Top Sellers
| 1 | -$4.91M | |
| 2 | -$3.86M | |
| 3 | -$3.77M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.36M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$866K |